Effect of inhaled budesonide on lung function and airway inflammation: Assessment by various inflammatory markers in mild asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 1, 1999, Pages 22-30

  Lim, Sam ^a   Jatakanon, Anon ^a   John, Matthias ^a   Gilbey, Thomas ^a   O'Connor, Brian J ^a   Chung, Kian Fan ^a   Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; METHACHOLINE; NITRIC OXIDE; SALBUTAMOL;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHUS BIOPSY; BRONCHUS REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG LAVAGE; MALE; POWDER INHALER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0032924480     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.1.9706006     Document Type: Article

References (30)

1. Barnes, P. J., and S. A. Kharitonov. 1996. Exhaled nitric oxide: a new lung function lest. Thorax 51:233-237.
2. Pin, I., P. G. Gibson, R. Kolendowicz, A. Girgis-Gabardo, J. A. Denburg, F. E. Hargreave, and J. Dolovich. 1992. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 47: 25-29.
3. Oddera, S., M. Silvestri, A. Balbo, B. O. Jovovich, R. Penna, E. Crimi, and G. A. Rossi. 1996. Airway eosinophilic inflammation, epithelial damage, and bronchial hyperresponsiveness in patients with mild-moderate, stable asthma. Allergy 51:100-107.
4. Jatakanon, J., S. Lim, K. F. Chung, and P. J. Barnes. 1997. Correlation between exhaled nitric oxide, sputum eosinophils and methacholine responsiveness (abstract). Am. J. Respir. Crit. Care Med. 155:A819.
5. Kharitonov, S. A., D. H. Yates, and P. J. Barnes. 1996. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am. J. Respir. Crit. Care Med. 153:454-457.
6. Trigg, C. J., N. D. Manolitsas, J. Wang, M. A. Calderon, A. McAulay, S. E. Jordan, M. J. Herdman, N. Jhalli, J. M. Duddle, S. A. Hamilton, J. L. Devalia, and R. J. Davies. 1994. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am. J. Respir. Crit. Care Med. 150:17-22.
7. Keatings, V. M., A. Jatakanon, M. Worsdell, and P. J. Barnes. 1997. Effect of inhaled and oral glucocorticosteroids on inflammatory indices in asthma and COPD. Am. J. Respir. Crit. Care Med. 155:542-548.
8. Keatings, V. M., B. J. O'Connor, L. G. Wright, D. P. Huston, C. J. Corrigan, and P. J. Barnes. 1997. Late response to allergen is associated with increased concentrations on TNF-α and interleukin-5 in induced sputum. J. Allergy Clin. Immunol. 99:693-698.
9. Altman, D. G. 1991. Practical Statistics for Medical Research. Chapman & Hall, London. 467-471.
10. Smith, J. M., and G. F. Devey. 1968. Clinical trial of disodium cromoglycate in treatment of asthma in children. B.M.J. 2:340-344.
11. Juniper, E. F., P. A. Kline, M. A. Vanzieleghem, E. H. Ramsdale, P. M. O'Byrne, and F. E. Hargreave. 1990. Long-term effects of budesonide on airway responsiveness and clinical asthma severity in inhaled steroid-dependent asthmatics. Eur. Respir. J. 3:1122-1127.
12. Kharitonov, S. A., D. Yates, R. A. Robbins, R. Logan-Sinclair, E. A. Shinebourne, and P. J. Barnes. 1994. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343:133-135.
13. Nijkamp, F. P., and G. Folkerts. 1995. Nitric oxide and bronchial hyperresponsiveness. Arch. Int. Pharmacodyn. Ther. 329:81-96.
14. Broide, D. H., M. Lotz, A. J. Cuomo, D. A. Coburn, E. C. Federman, and S. I. Wasserman. 1992. Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89:958-967.
15. Barnes, P. J. 1995. Nitric oxide and airway disease. Ann. Med. 27:389-393.
16. Kharitonov, S. A., B. J. O'Connor, D. J. Evans, and P. J. Barnes. 1995. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am. J. Respir. Crit. Care Med. 151:1894-1899.
17. Yates, D. H., S. A. Kharitonov, R. A. Robbins, P. S. Thomas, and P. J. Barnes. 1995. Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am. J. Respir. Crit. Care Med. 152:892-896.
18. Gelder, C. M., P. S. Thomas, D. H. Yates, I. M. Adcock, J. F. Morrison, and P. J. Barnes. 1995. Cytokines expression in normal, atopic, and asthmatic subjects using the combination of sputum induction and the polymerase chain reaction. Thorax 50:1033-1037.
19. Hargreave, F. E., T. Popov, J. Kidney, and J. Dolovich. 1993. Sputum measurement to assess airway inflammation in asthma. Allergy 48: 81-86.
20. 1985. Summary and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in asthmatics. Am. Rev. Respir. Dis. 132:180-182.
21. Woolley, K. L., E. Adelroth, M. J. Woolley, R. Ellis, M. Jordana, and P. M. O'Byrne. 1995. Effects of allergen challenge on eosinophils, eosinophil cationic protein, and granulocyte-macrophage colony-stimulating factor in mild asthma. Am. J. Respir. Crit. Care Med. 151: 1915-1924.
22. Laitinen, L. A., A. Laitinen, and T. Haahtela. 1993. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am. Rev. Respir. Dis. 147:697-704.
23. Sont, J. K., J. Han, J. M. van-Krieken, C. E. Evertse, R. Hooijer. L. N. Willems, and P. J. Sterk. 1996. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax 51:496-502.
24. Bousquet, J., P. Chanez, J. Y. Lacoste, G. Barneon, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard, and F. B. Michel. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
25. Richmond, I., H. Booth, C. Ward, and E. H. Walters. 1996. Intrasubject variability in airway inflammation in biopsies in mild to moderate stable asthma. Am. J. Respir. Crit. Care Med. 153:899-903.
26. Bentley, A. M., Q. Meng, D. S. Robinson, Q. Hamid, A. B. Kay, and S. R. Durham. 1993. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am. J. Respir. Cell Mol. Biol. 8:35-42.
27. Hallsworth, M. P., C. P. Soh, S. J. Lane, J. P. Arm, and T. H. Lee. 1994. Selective enhancement of GM-CSF, TNF-alpha, IL-1 beta and IL-8 production by monocytes and macrophages of asthmatic subjects. Eur. Respir. J. 7:1096-1102.
28. British Thoracic Society. 1997. The British guidelines on asthma management. Thorax 52(Suppl.):S2-S8.
29. Maestrelli, P., M. Saetta, A. di Stefano, P. G. Calcagni, G. Turato, M. P. Ruggieri, A. Roggeri, C. E. Mapp, and L. M. Fabbri. 1995. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am. J. Respir. Crit. Care Med. 152:1926-1931.
30. Sont, J. K., L. N. Willems, E. H. Bel, C. E. Evertse, J. P. Vandenbroucke, and P. J. Sterk. 1997. The clinical control of asthma after adding airway hyperresponsiveness (AHR) to the guides of long-term therapy: a two year randomised trial. Eur. Respir. J. 10(Suppl. 25):194s.